Physician profile
Mark Wayne Kolasa
NPI 1528079324
$4,688.95
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $22.54 · 2021: $153 · 2022: $371 · 2023: $2,885 · 2024: $1,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,008 · Travel and Lodging: $1,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,008.31 |
| Travel and Lodging | $1,988.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,380.66 | 2022-2024 | Micra, Plasmablade(Tm) |
| Atricure, INC. | $239.75 | 2019-2024 | |
| Biotronik INC. | $151.17 | 2021-2024 | Rivacor 7 Dr-T |
| Abbott Laboratories | $147.65 | 2021-2024 | Cool Point, Jot Dx |
| Irhythm Technologies, INC. | $126.84 | 2022-2023 | Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Amgen INC. | $119.47 | 2022-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $84.29 | 2020-2024 | Camzyos |
| Philips North America LLC | $71.64 | 2022-2023 | |
| Medtronic Vascular, INC. | $51.04 | 2019 | |
| Elutia, INC. | $37.34 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.40 | 2021-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $25.03 | 2023 | |
| Cardiva Medical, INC. | $22.37 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $21.07 | 2024 | Wainua |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $19.93 | 2022 | |
| Novo Nordisk INC | $19.15 | 2023 | Ozempic |
| Pfizer INC. | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kolasa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.